Stockhub

Herantis Pharma Oyj: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 August 2022

13 August 2022

10 August 2022

  • curprev 01:1201:12, 10 August 2022‎ 109.180.50.163 talk‎ 573 bytes +573‎ Created page with "Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Herantis_Pharma_Oyj’